HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficiency of afala in complex therapy of patients with chronic prostatitis.

Abstract
The use of afala in complex treatment of patients with chronic prostatitis improves the efficiency of therapy and prolongs its positive results. The preparation is well tolerated, has no contraindication, and can be combined with other drugs. Afala is indicated for patients with stages II and IIIa chronic prostatitis from the first day of therapy.
AuthorsE V Kul'chavenya
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 148 Issue 2 Pg. 315-7 (Aug 2009) ISSN: 1573-8221 [Electronic] United States
PMID20027357 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antibodies
  • Immunologic Factors
  • afala
Topics
  • Adult
  • Antibodies (therapeutic use)
  • Chronic Disease
  • Humans
  • Immunologic Factors (therapeutic use)
  • Male
  • Middle Aged
  • Pain (drug therapy, pathology)
  • Prostatitis (drug therapy, metabolism, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: